MedDataX Logo

Intelligent Diagnosis and Treatment Model for Insomnia Disorder

NCT ID: NCT06375447

Last Updated: 2024-12-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

16000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-12-01

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To establish a multicenter, multi-dimensional cohort on insomnia disorder and to develop an intelligent model for the diagnosis and treatment of insomnia disorder.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study endeavors to establish a multicenter cohort comprising 16,000 individuals diagnosed with insomnia disorder, with a subsequent 2-year follow-up. Objectives encompass elucidating the natural development of insomnia disorder within diverse populations, identifying associated factors, and evaluating the short-term and long-term impacts on physiological, psychological, and social functions in insomnia disorder. Additionally, the research aims to devise early screening methodologies, precise assessments, and innovative disease classifications utilizing real-time assessment technology within the insomnia disorder cohort. Furthermore, the investigation seeks to ascertain graded diagnoses, treatment modalities, and prognostic indicators based on advanced multi-dimensional real-time assessment technology applied to a substantial insomnia disorder cohort. Finally, the study aims to refine remote interactive diagnostic and treatment modalities tailored to diverse age groups, culminating in developing a systematic graded diagnostic and treatment framework for insomnia disorder.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Insomnia

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Insomnia Intelligence Model Prediction Differential diagnosis and treatment System

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with insomnia

Patients with a complaint about insomnia.

Routine clinical treatment

Intervention Type OTHER

Routine clinical treatment is based on the latest international guidelines for insomnia.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Routine clinical treatment

Routine clinical treatment is based on the latest international guidelines for insomnia.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. A complaint of insomnia;
2. Age between 18 and 75;
3. Able to fill out the scale on their own;
4. Agree to sign the informed consent to participate in the study and cooperate in completing the follow-up visit.

Exclusion Criteria

1.A current or history of comorbid Axis I psychiatric disorders.
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

West China Hospital

OTHER

Sponsor Role collaborator

Beijing Tiantan Hospital

OTHER

Sponsor Role collaborator

Second Affiliated Hospital of Soochow University

OTHER

Sponsor Role collaborator

Chifeng City Center Hospital Ningcheng County

UNKNOWN

Sponsor Role collaborator

Xuanwu Hospital, Beijing

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hongxing Wang, MD & PhD

Role: STUDY_DIRECTOR

Xuanwu Hospital, Beijing

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Xuanwu Hospital, Capital Medical University

Beijing, , China

Site Status RECRUITING

Beijing Tiantan Hospital, Capital Medical University

Beijing, , China

Site Status RECRUITING

The First Bethune Hospital of Jilin University

Changchun, , China

Site Status NOT_YET_RECRUITING

West China Hospital, Sichuan University

Chengdu, , China

Site Status RECRUITING

The Second Affiliated Hospital of Soochow University

Suzhou, , China

Site Status NOT_YET_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Huang Wang, MD

Role: CONTACT

Phone: 01083198513

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Hongxing Wang, MD & PhD

Role: primary

Yi Zhang, MD & PhD

Role: primary

Zan Wang, MD & PhD

Role: primary

Lan Zhang, MD & PhD

Role: primary

Hua Hu, MD & PhD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Insomnia

Identifier Type: -

Identifier Source: org_study_id